Positron emission tomography to assess drug occupancy at peripheral and central incretin receptors
The study was funded by Uppsala Diabetes Center, Diabetesfonden, ExoDiab, Diabetes Wellness Sweden, Barndiabetesfonden, Science for Life Laboratory, and the Swedish Research Council.
Authors
- Irina Velikyan (ORCID: https://orcid.org/0000-0001-5315-6090)
- Amina Khalil (ORCID: https://orcid.org/0009-0007-8567-2277)
- Mengfei Xiong (ORCID: https://orcid.org/0000-0002-4666-3884)
- Martin Bossart
- Olof Eriksson (ORCID: https://orcid.org/0000-0002-2515-8790)
- Michael Wagner
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Science for Life Laboratory (SE)
- Sanofi (France) (FR)
- Viewpoints Research Institute (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1016/j.ebiom.2025.106033
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vetenskapsrådet
- Barndiabetesfonden
- Akademiska Sjukhuset
- Uppsala Universitet
- Diabetesfonden
- Science for Life Laboratory